FR2404009A1 - 7-azabenzimidazoles a chaine laterale basique, leur preparation et leurs utilisations therapeutiques - Google Patents

7-azabenzimidazoles a chaine laterale basique, leur preparation et leurs utilisations therapeutiques

Info

Publication number
FR2404009A1
FR2404009A1 FR7826249A FR7826249A FR2404009A1 FR 2404009 A1 FR2404009 A1 FR 2404009A1 FR 7826249 A FR7826249 A FR 7826249A FR 7826249 A FR7826249 A FR 7826249A FR 2404009 A1 FR2404009 A1 FR 2404009A1
Authority
FR
France
Prior art keywords
azabenzimidazoles
preparation
side chain
therapeutic uses
basic side
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7826249A
Other languages
English (en)
Other versions
FR2404009B1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Evonik Operations GmbH
Original Assignee
Degussa GmbH
Deutsche Gold und Silber Scheideanstalt
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Degussa GmbH, Deutsche Gold und Silber Scheideanstalt filed Critical Degussa GmbH
Publication of FR2404009A1 publication Critical patent/FR2404009A1/fr
Application granted granted Critical
Publication of FR2404009B1 publication Critical patent/FR2404009B1/fr
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/74Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/75Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Ces 7-azabenzimidazoles répondent à la formule I ci-après ; pour les préparer, on condense, avec formation d'un cycle imidazole, un composé de formule II avec un composé de. formule III, le composé obtenu pouvant, le cas échéant, être soumis à alkylation et/ou acylation et éventuellement converti en un sel. Ces composés sont des médicaments utiles notamment en raison de leur activité anti-ulcérogène.
FR7826249A 1977-09-26 1978-09-13 7-azabenzimidazoles a chaine laterale basique, leur preparation et leurs utilisations therapeutiques Granted FR2404009A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB3991977 1977-09-26

Publications (2)

Publication Number Publication Date
FR2404009A1 true FR2404009A1 (fr) 1979-04-20
FR2404009B1 FR2404009B1 (fr) 1981-09-18

Family

ID=10412196

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7826249A Granted FR2404009A1 (fr) 1977-09-26 1978-09-13 7-azabenzimidazoles a chaine laterale basique, leur preparation et leurs utilisations therapeutiques

Country Status (20)

Country Link
US (1) US4247556A (fr)
JP (1) JPS5455595A (fr)
AR (1) AR219948A1 (fr)
AT (1) AT365188B (fr)
BE (1) BE870709A (fr)
CA (1) CA1103673A (fr)
DD (1) DD139579A5 (fr)
DE (1) DE2841209A1 (fr)
DK (1) DK424678A (fr)
EG (1) EG13604A (fr)
ES (1) ES473201A1 (fr)
FI (1) FI782909A (fr)
FR (1) FR2404009A1 (fr)
IT (1) IT7851230A0 (fr)
NL (1) NL7809713A (fr)
NO (1) NO783239L (fr)
PT (1) PT68584A (fr)
SE (1) SE7810050L (fr)
SU (1) SU795478A3 (fr)
ZA (1) ZA785430B (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0255217A1 (fr) * 1986-06-09 1988-02-03 A.H. ROBINS COMPANY, INCORPORATED (a Delaware corporation) Composés imidazohétérocycliques condensés

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR950001015B1 (ko) * 1986-01-10 1995-02-07 닛뽕 케미화 가부시끼가이샤 술폭시드 유도체의 제조방법
HUP0004024A3 (en) 1997-09-26 2001-10-29 Zentaris Gmbh Azabenzimidazole-based compounds, process for their preparation and pharmaceutical composition thereof
FR2832148B1 (fr) * 2001-11-14 2004-05-21 Oreal Nouvelles bases d'oxydation 2,5-diaminopyridine utiles pour la teinture des fibres keratiniques
US7989459B2 (en) 2006-02-17 2011-08-02 Pharmacopeia, Llc Purinones and 1H-imidazopyridinones as PKC-theta inhibitors
US20090281075A1 (en) * 2006-02-17 2009-11-12 Pharmacopeia, Inc. Isomeric purinones and 1h-imidazopyridinones as pkc-theta inhibitors
AR063141A1 (es) 2006-10-04 2008-12-30 Pharmacopeia Inc Derivados de 2- ( benzimidazolil ) purina 8- sustituida para inmunosupresion
US7902187B2 (en) 2006-10-04 2011-03-08 Wyeth Llc 6-substituted 2-(benzimidazolyl)purine and purinone derivatives for immunosuppression
CL2007002866A1 (es) 2006-10-04 2008-07-04 Pharmacopeia Inc Compuestos derivados de 6-sustituidos-2-(bencimidazolil) purina y purinona; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto en el tratamiento de enfermedades autoinmunes, enfermedad inflamatoria, enfermedad mediada por m
WO2014145852A2 (fr) 2013-03-15 2014-09-18 Knopp Biosciences Llc Imidazo(4,5-b) pyridine-2-yl amides en tant que d'activateurs du canal kv7
ES2960991T3 (es) 2014-09-12 2024-03-07 Biohaven Therapeutics Ltd Benzoimidazol-1,2-ilamidas como activadores del canal Kv7

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB945147A (en) * 1959-03-18 1963-12-23 Ciba Ltd Aza-benzimidazoles
US4002623A (en) * 1974-08-07 1977-01-11 Pfizer Inc. Anti-inflammatory 1-[3-(dialkylamino)propyl]-2-acylaminobenzimidazoles and 2-acylamino-3-[3-(dialkylamino)-propyl]imidazo[4,5-b]pyridines

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3004978A (en) * 1961-10-17 Certain i-tert-amino lower alkyl
US2987518A (en) * 1958-12-10 1961-06-06 Ciba Pharmacentical Products I Certain 1h [4, 5-c]-imidazopyridines
US3719683A (en) * 1970-11-20 1973-03-06 Ciba Geigy Corp Imidazo(4,5-b)pyridines
US4059584A (en) * 1974-08-07 1977-11-22 Pfizer 2-Acylamino-3-[3-(dialkylamino)propyl]imidazo[4,5-b]pyridines
SE422799B (sv) * 1975-05-28 1982-03-29 Merck & Co Inc Analogiforfarande for framstellning av 1,3-dihydroimidazo (4,5-b)pyridin-2-oner

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB945147A (en) * 1959-03-18 1963-12-23 Ciba Ltd Aza-benzimidazoles
US4002623A (en) * 1974-08-07 1977-01-11 Pfizer Inc. Anti-inflammatory 1-[3-(dialkylamino)propyl]-2-acylaminobenzimidazoles and 2-acylamino-3-[3-(dialkylamino)-propyl]imidazo[4,5-b]pyridines

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0255217A1 (fr) * 1986-06-09 1988-02-03 A.H. ROBINS COMPANY, INCORPORATED (a Delaware corporation) Composés imidazohétérocycliques condensés

Also Published As

Publication number Publication date
ATA690278A (de) 1981-05-15
BE870709A (fr) 1979-03-22
FR2404009B1 (fr) 1981-09-18
NL7809713A (nl) 1979-03-28
US4247556A (en) 1981-01-27
ZA785430B (en) 1979-09-26
ES473201A1 (es) 1979-03-16
DD139579A5 (de) 1980-01-09
SU795478A3 (ru) 1981-01-07
DE2841209A1 (de) 1979-04-05
EG13604A (en) 1982-03-31
DK424678A (da) 1979-03-27
SE7810050L (sv) 1979-03-27
JPS5455595A (en) 1979-05-02
AT365188B (de) 1981-12-28
AR219948A1 (es) 1980-09-30
IT7851230A0 (it) 1978-09-25
FI782909A (fi) 1979-03-27
PT68584A (de) 1978-10-01
CA1103673A (fr) 1981-06-23
NO783239L (no) 1979-03-27

Similar Documents

Publication Publication Date Title
FR2387945A1 (fr) Agents favorisant la croissance des plantes et phytoprotecteurs a base d'oximethers et d'oximesters
IT7848640A0 (it) Procedimento per la produzione dicomposti poliossidrilici a basso peso molecolare
FR2379534A1 (fr) 1-thienyl- et furyl-2,3,4,5-tetrahydro-1h-3-benzazepine substituees
OA06063A (fr) Dérivés de l'anthelmintique C-076.
FR2384773A1 (fr) Nouveaux composes heterocycliques a activite spasmolytique
FR2404009A1 (fr) 7-azabenzimidazoles a chaine laterale basique, leur preparation et leurs utilisations therapeutiques
IT7926935A0 (it) Procedimento eterogeneo per lapreparazione di 1,1-diesteri.
FR2367427A1 (fr) Produits a base de thiadiazolyl-uree permettant d'agir sur la croissance des plantes
OA07525A (fr) Dérivés d'acides-animés, leur préparation et utilisation ainsi que les compositions contenant ces dérivés.
ATE84515T1 (de) Antikrebsverbindungen.
IT8323898A0 (it) Composizione anti-acne contenent,come composto attivo, un derivato dell'isotiazolo-(5,4b) piridinone-3.
FR2422658A1 (fr) Composes piperazinyl-benzoheterocycliques, leur preparation et leurs utilisations therapeutiques
FR2405657A1 (fr) Agent favorisant la croissance des animaux
FR2367742A1 (fr) Derives d'a-thio-alcanoiques, leur preparation et leur utilisation
FR2392990A1 (fr) Medicament a base d'un compose heterocyclique bicyclique condense
FR2442226A1 (fr) Anilines substituees, leur preparation et leurs utilisations
IE37717L (en) N-BENZHYDRYL-N'-p-HYDROXYBENZYL-PIPERAZINES.
FR2389597A1 (fr)
FR2378518A1 (fr) Nouveaux medicaments a base de derives de tetrahydrodibenzopyranne
FR2375223A1 (fr) 1,2,6-thiadiazinones, leur preparation et leurs utilisations
FR2401922A1 (fr) Picolylamides d'acides 4-hydroxy-isophtaliques substitues, leur preparation et leurs utilisations therapeutiques
FR2426690A2 (fr) Composes de rifamycine
FR2433516A1 (fr) Pyridoxines, leur preparation et leurs utilisations therapeutiques
FR2372792A1 (fr) Aminoalcoxybenzenes, leur preparation et leurs utilisations therapeutiques
FR2423491A1 (fr) Composes heterocycliques azotes, en particulier n-imidazolylamino-iso-indolines, et medicaments qui en contiennent

Legal Events

Date Code Title Description
ST Notification of lapse